SCHEMBL20341538

SCHEMBL20341538

CC(C)(C)OC(=O)CC[C@H](NC(=O)N[C@@H](CCCCNC(=O)CN)C(=O)OC(C)(C)C)C(=O)OC(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 8/20 0.43
▸ ATM Q13315 2/20 0.41
▸ FOLH1 Q04609 4/20 0.41
▸ NPSR1 Q6W5P4 8/20 0.40
▸ KMT2A Q03164 5/20 0.40
▸ MEN1 O00255 4/20 0.40
▸ POLB P06746 3/20 0.40
▸ MAPT P10636 5/20 0.39
▸ EPHX2 P34913 1/20 0.37
▸ KDM4E B2RXH2 2/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ PAX8 Q06710 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20341481 1.00 TDP1 (0.43) TDP1ATMFOLH1NPSR1KMT2A
SCHEMBL25963705 0.89 TDP1 (0.43) TDP1ATMFOLH1NPSR1KMT2A
SCHEMBL18396046 0.89 FOLH1 (0.41) TDP1ATMFOLH1NPSR1KMT2A
SCHEMBL30031700 0.89 FOLH1 (0.41) TDP1ATMFOLH1NPSR1KMT2A
SCHEMBL18396048 0.89 FOLH1 (0.41) TDP1ATMFOLH1NPSR1KMT2A
SCHEMBL16010862 0.89 FOLH1 (0.41) TDP1ATMFOLH1NPSR1KMT2A
SCHEMBL16010863 0.89 FOLH1 (0.41) TDP1ATMFOLH1NPSR1KMT2A
SCHEMBL23780010 0.87 EPHX2 (0.38) TDP1ATMFOLH1NPSR1KMT2A
SCHEMBL23780008 0.87 EPHX2 (0.38) TDP1ATMFOLH1NPSR1KMT2A
SCHEMBL18770775 0.87 KMT2A (0.43) TDP1FOLH1NPSR1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210032286-A1 PSMA Imaging Agents SIEMENS MEDICAL SOLUTIONS USA, INC. 2021-02-04 — — US disclosed
US-20210024574-A1 PSMA Imaging Agents SIEMENS MEDICAL SOLUTIONS USA, INC. 2021-01-28 — — US disclosed
US-10894807-B2 PSMA imaging agents SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2021-01-19 — — US disclosed
US-20200377549-A1 PSMA Imaging Agents SIEMENS MEDICAL SOLUTIONS USA, INC. 2020-12-03 — — US disclosed
US-10011632-B2 PSMA imaging agents SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2018-07-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10894807-B2 PSMA imaging agents FOLH1, KLK3, PSMA2 TDP1 2960/4885ATM 1557/4885FOLH1 1/4885
US-20200377549-A1 PSMA Imaging Agents FOLH1, KLK3, PSMA2 TDP1 2960/4885ATM 1557/4885FOLH1 1/4885
US-20210032286-A1 PSMA Imaging Agents FOLH1, KLK3, PSMA2 TDP1 2960/4885ATM 1557/4885FOLH1 1/4885
US-10011632-B2 PSMA imaging agents FOLH1, KLK3, PSMA2 TDP1 2960/4885ATM 1557/4885FOLH1 1/4885
US-20210024574-A1 PSMA Imaging Agents FOLH1, KLK3, PSMA2 TDP1 2960/4885ATM 1557/4885FOLH1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback